GIQuant is FDA Cleared (Class II) and CE Marked (Class IIa), it can be used for adults and children with routine MRE data.
- GIQuant® can track disease response to a range of interventions objectively, this may lead to a reduction in time on ineffective therapies
- GIQuant® allows for disease activity analysis without the need for IV gadolinium and can process historic data to see patient motility over time
- GIQuant® is validated with both breath-hold and free breathing dynamic MRI data
Precision medicine is about ensuring the right patient gets the right medication at the right time. We’re not there yet with Crohn’s disease, if we can track response closely and objectively we can identify times where medications stop working and make a change, optimising treatment.
When a patient presents with a flare, their GIQuant score is likely to be low. They’ll be started on anti-inflammatory medications and, where the treatment is successful, their GIQuant score will usually increase. The GIQuant score can be quoted from routine MRE data alongside the routine tests providing a supplementary, quantitative input for the gastroenterologists treatment plan.
GIQuant does not replace the routine MRE exam or an experienced Radiologist but it does not need gadolinium or a spasmolytic. GIQuant can be used in a shorter, follow up scan potentially at an earlier date to examine treatment response and get the patient on the right track sooner.